|
The presentation will include an overview of the emerging continuum
of care for stroke patients with an emphasis on emerging technologies
and practice patterns for the prevention and treatment of stroke.
Molecular diagnostics, imaging and endovascular approaches will become
the standard of care for triaging, assessing and treating patients with
stroke. As technology changes the way care is delivered so will it
change the providers who will dominate stroke care. The presentation
will also introduce the emerging stroke team and discuss the importance
of key members in the future of care for stroke patients.
Objectives
At the conclusion of this program, participants should be able to:
-
Describe the emerging role of endovascular approaches in the
treatment of acute stroke.
-
Describe the emerging use of endovascular approaches in the
prevention of stroke.
-
Describe the use of imaging and emerging imaging applications in
stroke patient assessment and treatment planning.
-
Describe emerging pharmaceutical alternatives to tPA for the
disruption of stroke causing emboli.
Presenter
Jayme L. M. Zage, PhD is the Content Lead and
Director of Sg2's Neurosciences Intelligence Program. She brings to Sg2
a diversified background that includes research in neurobiology and
cardiovascular disease and consulting in the pharmaceutical sector. Over
the past several years, Jayme has led content development for a number
of Sg2 publications, including Briefings and Focus Reports on
neurosciences and women's health topics. She has provided consulting and
strategic planning services for a variety of clients.
Jayme received her PhD from Columbia University in New York City,
where her research and studies focused on understanding the molecular
mechanism of disease. Her examination of basic cellular
function—specifically, endocytic membrane trafficking—can be applied to
a number of diseases, including diabetes, Alzheimer’s disease, viral and
bacterial infection and cystic fibrosis. Jayme remained at Columbia as
an NIH-funded postdoctoral fellow, researching the function of neuronal
proteins, molecules that have been implicated in a number of diseases
including ALS. In her postdoctoral training at the University of
Chicago, she examined the role of presenilin in Alzheimer’s disease. Her
findings are published in several leading journals. Prior to joining
Sg2, Jayme worked with Technomic International in their pharmaceutical
group, and at Abbott Laboratories in the company’s drug-coated stent
program. These experiences extend her field of expertise to include drug
development, marketing and regulatory.
Continuing Education Credit
Available through – November 8, 2008
A Pharmacy Continuing Education Activity (1.0 Contact Units)
262-000-07-088-L04
Consorta is accredited by the Accreditation Council for Pharmacy
Education as a Provider of continuing pharmaceutical education.
A Nursing Continuing Education Activity (1.0 hours) 0509-7107
This session has been approved for continuing nursing education
contact hours through the Illinois Nurses Association, an accredited
approver by the American Nurses Credentialing Center’s Commission on
Accreditation.
|